10th Annual MSK Symposium on Lymphoma

Join us for the 10th anniversary edition of the MSK Symposium on Lymphoma, marking a decade of advances in lymphoma diagnosis, management, and therapy. This one-and-a-half-day symposium will explore the rapidly evolving landscape of lymphoma research and clinical practice, highlighting advances in disease biology, diagnostic approaches, and therapeutic strategies that are transforming patient outcomes.

The program offers a comprehensive review of the clinical management of both common and emerging lymphoma subtypes. Through expert-led lectures, interactive panel discussions, and practical clinical guidance, faculty will share the latest evidence and insights to support informed, individualized decision-making in an era of accelerating innovation. Key highlights include: 

• Keynote Lectures: Presented by internationally recognized leaders in lymphoma biology, translational research, and clinical care.

• Interactive Panel Discussions: Case-based conversations addressing evolving treatment paradigms and real-world clinical challenges.

• Allied Health Professionals Session: A dedicated session for the interprofessional care team, highlighting their essential and expanding role in lymphoma management. Please note that space is limited for this session.

• Networking Opportunities: Connect with colleagues and faculty throughout the program, including a 10th anniversary reception on Friday evening and a farewell luncheon on Saturday afternoon.

Participants will gain insight into the scientific advances shaping lymphoma biology and pathology, and how these discoveries are being translated into clinical practice. This program brings together distinguished experts from MSK and institutions across the United States and around the world to advance education, collaboration, and patient-centered care—helping to shape the future of lymphoma care. A detailed agenda, including topics and faculty, will be released soon.

Target Audience: This symposium is designed for internists, hematologists, medical and radiation oncologists, hematopathologists, scientists, and medical trainees who are involved in the diagnosis, treatment, and biomedical research of lymphoma. Participants have the option to attend in person or virtually.

Online Syllabus: After the symposium concludes, participants will have access to an online syllabus that includes recorded faculty presentations and PDF copies of presentation slides.

1. Describe recent advances in lymphoma diagnosis, helping navigate with recent advances in the WHO and ICC classifications
2. Discuss first line treatment options in most frequent lymphoma entities
3. Describe new agents mode of actions, efficacy, side effects
4. Discuss options and recommendations for patients in the relapse refractory setting
5. Provide strategies to help shared decision-making with patients regarding their treatment

We are pleased to offer early discounted registration through February 13, 2026.

Early Registration Fees (In-Person or Virtual)

• Physicians (MDs, PhDs, DOs): $400

• Advanced Practice Providers: $150

• Nurses and Other Healthcare Professionals: $100*

• Residents, Fellows, and Trainees: $50*

• Industry Professionals: N/A (general rates apply)**

• MSK Employees: Complimentary***

General Registration Fees (In-Person or Virtual)

• Physicians (MDs, PhDs, DOs): $450

• Advanced Practice Providers: $200

• Nurses and Other Healthcare Professionals: $150

• Residents, Fellows, and Trainees: $100*

• Industry Professionals: $785**

• MSK Employees: Complimentary***

Registration Discounts: Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Cancellation Policy: For details on our cancellation terms, please review our Cancellation Policy.

*Certain registration rates are non-refundable. Please review the cancellation policy above for additional information.
**An industry professional is defined as any individual, irrespective of their provider type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. Please review our Registration Policy for Industry Professionals for more information.
***MSK employees receive complimentary registration for all CME programs by signing in with MSK credentials (SSO).

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity is approved for:

• AMA PRA Category 1 Credit™ 

• ABIM Maintenance of Certification (MOC)

• ABPath Continuing Certification (CC).

An application has been submitted for ANCC Nursing contact hours.

MSK Symposium Director

Gilles Salles, MD, PhD
Chief, Lymphoma Service

MSK Planning Committee

Ahmet Dogan, MD, PhD
Chief, Hematopathology Service

Lauren Drosick, PA-C
Advanced Practice Provider

Kojo S.J. Elenitoba-Johnson, MD
Chair, Department of Pathology and Laboratory Medicine 

Steven Horwitz, MD
Attending Physician, Lymphoma Service

Andrew Intlekofer, MD, PhD
Assistant Member, Human Oncology & Pathogenesis Program

Alison J. Moskowitz, MD
Associate Attending Physician, Lymphoma  Service

Ariela Noy, MD
Member, Lymphoma Service

Kishan Patel, MD
Hematology/Oncology Fellow

Hans-Guido Wendel, MD
Member/Professor, Cancer Biology and Genetics Program

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.